| Literature DB >> 17464965 |
Faqin Jiang1, Qinjie Weng, Rong Sheng, Qing Xia, Qiaojun He, Bo Yang, Yongzhou Hu.
Abstract
A series of novel 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives were synthesized and screened for their in vitro cytotoxicity against promyelocytic leukemia HL-60, androgen-independent prostate tumor PC3, hepatocellular carcinoma Bel-7402, human esophagus tumor ECA-109, and human breast tumor MCF-7 cell lines in hypoxia and in normoxia. Most compounds showed higher cytotoxic activity both in hypoxia and in normoxia. Among them, compounds 61 and 62 showed more potent cytotoxic activity and hypoxic selectivity when compared to tirapazamine.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17464965 DOI: 10.1002/ardp.200600201
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751